Aptamer-modified magnetic nanoprobe for molecular MR imaging of VEGFR2 on angiogenic vasculature

Nanoscale Research Letters

Volumn 8, Issue 1, 2013, Pages 1-10

  Kim, Bongjune ^a   Yang, Jaemoon ^b   Hwang, Myeonghwan ^b   Choi, Jihye ^a   Kim, Hyun Ouk ^a   Jang, Eunji ^a   Lee, Jung Hwan ^c   Ryu, Sung Ho ^c   Suh, Jin Suck ^b   Huh, Yong Min ^b   Haam, Seungjoo ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Angiogenesis; Aptamer; Magnetic nanocrystal; Magnetic resonance imaging; Molecular imaging; VEGFR2

Indexed keywords

DECOMPOSITION; MAGNETIC RESONANCE IMAGING; MAGNETISM; NANOCRYSTALS; NANOPROBES; NUCLEIC ACIDS;

ANGIOGENESIS; APTAMERS; MAGNETIC NANOCRYSTALS; SPECIFIC DETECTION; THERMAL DECOMPOSITION METHODS; VASCULAR GROWTH FACTORS; VEGFR-2; WATER SOLUBILIZATION;

MOLECULAR IMAGING;

EID: 84887270439     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-8-399     Document Type: Article

References (26)

1. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ: In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotech 2000, 18:321-325.
2. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP: In vivo magnetic resonance imaging of transgene expression. Nat Med 2000, 6:351-354.
3. Lee JH, Huh YM, Jun YW, Seo JW, Jang JT, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS, Cheon J: Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13:95-99.
4. Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, Muldoon LL, Neuwelt EA: Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 2009, 30:15-35.
5. Yang J, Lee ES, Noh MY, Koh SH, Lim EK, Yoo AR, Lee K, Suh JS, Kim SH, Haam S, Huh YM: Ambidextrous magnetic nanovectors for synchronous gene transfection and labeling of human MSCs. Biomaterials 2011, 32:6174-6182.
6. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA: Molecular imaging of angiogenesis in early-stage atherosclerosis with αvβ3-integrin-targeted nanoparticles. Circulation 2003, 108:2270-2274.
7. Massoud TF, Gambhir SS: Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003, 17:545-580.
8. Park J, Yang J, Lim EK, Kim E, Choi J, Ryu JK, Kim NH, Suh JS, Yook JI, Huh YM, Haam S: Anchored proteinase-targetable optomagnetic nanoprobes for molecular imaging of invasive cancer cells. Angewandte Chemie Int Ed 2012, 51:945-948.
9. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007, 21:2683-2710.
10. Veiseh O, Sun C, Fang C, Bhattarai N, Gunn J, Kievit F, Du K, Pullar B, Lee D, Ellenbogen RG, Olson J, Zhang M: Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 2009, 69:6200-6207.
11. Cho EJ, Yang J, Mohamedali KA, Lim EK, Kim EJ, Farhangfar CJ, Suh JS, Haam S, Rosenblum MG, Huh YM: Sensitive angiogenesis imaging of orthotopic bladder tumors in mice using a selective magnetic resonance imaging contrast agent containing VEGF121/rGel. Invest Radiol 2011, 46:441-449. doi:10.1097/RLI.0b013e3182174fad.
12. Klement G, Huang P, Mayer B, Green SK, Man S, Bohlen P, Hicklin D, Kerbel RS: Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts. Clin Cancer Res 2002, 8:221-232.
13. Ellington AD, Szostak JW: In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
14. Yigit MV, Mazumdar D, Kim HK, Lee JH, Odintsov B, Lu Y: Smart "Turn-on" magnetic resonance contrast agents based on aptamer-functionalized superparamagnetic iron oxide nanoparticles. ChemBioChem 2007, 8:1675-1678.
15. Sun S, Zeng H, Robinson DB, Raoux S, Rice PM, Wang SX, Li G: Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 2003, 126:273-279.
16. Lim EK, Yang J, Suh JS, Huh YM, Haam S: Self-labeled magneto nanoprobes using tri-aminated polysorbate 80 for detection of human mesenchymal stem cells. J Mater Chem 2009, 19:8958-8963.
17. Anton N, Benoit JP, Saulnier P: Design and production of nanoparticles formulated from nano-emulsion templates - a review. J Control Release 2008, 128:185-199.
18. McCarthy JR, Weissleder R: Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008, 60:1241-1251.
19. Yang J, Eom K, Lim EK, Park J, Kang Y, Yoon DS, Na S, Koh EK, Suh JS, Huh YM, Kwon TY, Haam S: In situ detection of live cancer cells by using bioprobes based on Au nanoparticles. Langmuir 2008, 24:12112-12115.
20. Choi J, Yang J, Park J, Kim E, Suh JS, Huh YM, Haam S: Specific near-IR absorption imaging of glioblastomas using integrin-targeting gold nanorods. Adv Funct Mater 2011, 21:1082-1088.
21. Zhang Y, Yang M, Portney N, Cui D, Budak G, Ozbay E, Ozkan M, Ozkan C: Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells. Biomed Microdevices 2008, 10:321-328.
22. Jung CW, Jacobs P: Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995, 13:661-674.
23. Koutcher JA, Hu X, Xu S, Gade TP, Leeds N, Zhou XJ, Zagzag D, Holland EC: MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials. Neoplasia 2002, 4:480-485.
24. McConville P, Hambardzumyan D, Moody JB, Leopold WR, Kreger AR, Woolliscroft MJ, Rehemtulla A, Ross BD, Holland EC: Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma. Clin Cancer Res 2007, 13:2897-2904.
25. Van Furth WR, Laughlin S, Taylor MD, Salhia B, Mainprize T, Henkelman M, Cusimano MD, Ackerley C, Rutka JT: Imaging of murine brain tumors using a 1.5 Tesla clinical MRI System. Canadian J Neuro Sci 2003, 30:326-332.
26. Moats RA, Velan-Mullan S, Jacobs R, Gonzalez-Gomez I, Dubowitz DJ, Taga T, Khankaldyyan V, Schultz L, Fraser S, Nelson MD, Laug WE: Micro-MRI at 11.7 T of a murine brain tumor model using delayed contrast enhancement. Mol Imaging 2003, 2:150-158.